Understanding pros and cons of medical weight loss drugs: What you need to know
As the new year sparks a wave of weight loss resolutions and millions turn to weight loss medications, rising costs and the ...
Independence Blue Cross to exclude coverage for some drugs that get accelerated FDA approval
Independence Blue Cross has instituted an 18-month benefit exclusion on certain drugs that receive accelerated approval from ...
Hello Healthy: A New Year, New Options for Weight Loss and Better Health
Dignity Health January marks Healthy Weight Awareness Month, and with the new year, many are setting health and weight loss ...
Eli Lilly's Zepbound Can Now Be Covered by Medicare to Treat Sleep Apnea
Popular Eli Lilly weight-loss drug Zepbound can be covered by Medicare plans to treat sleep apnea after it received Food and ...
Weight-loss drugs like Ozempic may be up for Medicare price negotiations — will Trump support it?
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...
Business Wire12h
F45 Training Expands Partnership With Dr. B to Support Prescription Weight Loss Programs With New Holistic Approach
F45 Training Holdings Inc., a leading global fitness community known for innovative, high-energy group workouts, announced ...
Dietetics professor explains who should and should not embrace the latest weight-loss drugs
Holiday weight gain hits home for many come January. These days, folks making resolutions to slim down and get fit have an ...
Medicare To Cover Eli Lilly's Weight Loss Drug Zepbound For Obstructive Sleep Apnea Treatment
Medicare now covers Eli Lilly's Zepbound for obstructive sleep apnea, FDA-approved for obesity and sleep apnea treatment, ...
israelnewsonline20h
Medicare may cover Eli Lilly’s Zepbound for sleep apnea: Department of Health and Human Services agency
Both Novo Nordisk and Eli Lilly are studying their weight loss drugs to treat fatty liver disease, chronic kidney disease, ...
Ozempic, Trulicity among Medicare's priciest drugs, report finds
Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate prices concessions, Bloomberg reported. The company told USA TODAY that it would ...
Medicare can now cover Eli Lilly's Zepbound for sleep apnea, Health Department agency says
It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other ...